Stonegate Investment Group LLC Buys 206 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Stonegate Investment Group LLC raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 8.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,605 shares of the medical equipment provider’s stock after acquiring an additional 206 shares during the period. Stonegate Investment Group LLC’s holdings in Intuitive Surgical were worth $879,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of the stock. OFI Invest Asset Management bought a new position in shares of Intuitive Surgical during the third quarter valued at $25,000. Headinvest LLC bought a new stake in shares of Intuitive Surgical in the third quarter worth approximately $28,000. Stone House Investment Management LLC raised its holdings in shares of Intuitive Surgical by 100.0% during the third quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 50 shares during the last quarter. Householder Group Estate & Retirement Specialist LLC bought a new position in Intuitive Surgical during the third quarter valued at approximately $30,000. Finally, Truvestments Capital LLC boosted its holdings in Intuitive Surgical by 137.2% in the third quarter. Truvestments Capital LLC now owns 102 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 59 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 3.2 %

NASDAQ ISRG opened at $382.36 on Wednesday. Intuitive Surgical, Inc. has a 12 month low of $250.01 and a 12 month high of $403.76. The stock’s 50 day moving average is $386.82 and its 200 day moving average is $335.66. The stock has a market cap of $135.53 billion, a PE ratio of 76.02, a P/E/G ratio of 6.13 and a beta of 1.36.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last posted its earnings results on Tuesday, January 23rd. The medical equipment provider reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.48 by $0.12. The company had revenue of $1.93 billion during the quarter, compared to analysts’ expectations of $1.89 billion. Intuitive Surgical had a net margin of 25.24% and a return on equity of 13.11%. Intuitive Surgical’s quarterly revenue was up 16.6% on a year-over-year basis. During the same period last year, the company posted $0.91 earnings per share. On average, analysts forecast that Intuitive Surgical, Inc. will post 4.93 EPS for the current fiscal year.

Insider Buying and Selling

In other news, Director Alan J. Levy sold 2,000 shares of the business’s stock in a transaction dated Friday, January 26th. The shares were sold at an average price of $370.20, for a total value of $740,400.00. Following the sale, the director now directly owns 25,319 shares in the company, valued at approximately $9,373,093.80. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other Intuitive Surgical news, Director Alan J. Levy sold 2,000 shares of the company’s stock in a transaction that occurred on Friday, January 26th. The stock was sold at an average price of $370.20, for a total transaction of $740,400.00. Following the sale, the director now directly owns 25,319 shares in the company, valued at $9,373,093.80. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Gary S. Guthart sold 24,325 shares of Intuitive Surgical stock in a transaction that occurred on Monday, January 29th. The stock was sold at an average price of $376.06, for a total value of $9,147,659.50. Following the completion of the transaction, the chief executive officer now owns 9,425 shares of the company’s stock, valued at approximately $3,544,365.50. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 248,418 shares of company stock worth $95,927,097. Insiders own 0.80% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have weighed in on ISRG shares. Barclays boosted their target price on shares of Intuitive Surgical from $385.00 to $430.00 and gave the company an “overweight” rating in a research note on Thursday, January 25th. StockNews.com downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Thursday, February 29th. Wells Fargo & Company boosted their price target on Intuitive Surgical from $363.00 to $416.00 and gave the company an “overweight” rating in a research note on Friday, January 19th. Mizuho increased their price objective on shares of Intuitive Surgical from $350.00 to $390.00 and gave the stock a “neutral” rating in a research note on Thursday, January 25th. Finally, Truist Financial boosted their target price on shares of Intuitive Surgical from $390.00 to $435.00 and gave the company a “buy” rating in a research report on Wednesday, January 24th. Five analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $371.60.

Get Our Latest Analysis on Intuitive Surgical

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Read More

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.